Hannah N. Suber

Hannah N. Suber

Auto-generated profile, based on publicly available information

Hannah N. Suber

Wildlife Toxicology Laboratory, Texas Tech University, Lubbock, TX, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Animals
Verified
Journal Article
Open access
PDF file
JLJeremiah Leach
Jeremiah Leach
HSHannah N. Suber
Hannah N. Suber
EBEmilynn Banks
Emilynn Banks
Ashley KaskocsakAshley Kaskocsak
Ashley Kaskocsak
HVHenry Valencia
Henry Valencia
RKRonald J. Kendall
Ronald J. Kendall
Oxyspirura petrowi is a heteroxenous nematode that infects the harderian gland and other ocular tissues in birds. High-intensity infections often cause damage to the infected tissues. Due to the nature of the infection sites, treatment of O. petrowi in these hosts can be difficult. Fenbendazole (FBZ) is a common anthelmintic used to treat birds for helminth infections; however, little information exists as to the efficacy of the drug on O. petrowi infections. The present study aims to estimate lethal concentrations of FBZ to O. petrowi. Adult O. petrowi were maintained in vitro and exposed to doses of 5, 50, 100, and 200 µM concentrations of FBZ and included both negative and vehicle controls. Exposure lasted 7.5 days and lethality was determined for each treatment. Negative and vehicle controls did not differ, and both had 75% survival at the end of the treatment period. The percentage survivorship in ascending order of concentration, corrected for the controls, was 66.67%, 44.44%, 33.33%, and 0%. LC10, LC50, and LC90 estimates were 7.5 ± 0.26, 49.1 ± 1.69, and 163.2 ± 5.63 µM, respectively. In the context of known pharmacokinetics of FBZ in birds, a single oral dose of FBZ can achieve exposure levels that are lethal to O. petrowi, but the drug does not stay in the system long enough. Thus, treatment of O. petrowi infections will require multiple oral doses over several days.

1 January 2024 in Conservation Physiology
Verified
Journal Article
Open access
PDF file
JLJeremiah Leach
Jeremiah Leach
HSHannah N Suber
Hannah N Suber
KCKatelyn Conley
Katelyn Conley
RRRegan Rivera
Regan Rivera
JSJames Surles
James Surles
RKRonald J. Kendall
Ronald J. Kendall
Interest in the effects of stressors on wildlife has grown substantially over the past few decades. As this interest has grown, so has the need for minimally invasive and reliable methods for estimating differences in the levels of stress hormones. An enzyme immunoassay using standardized methods was validated for detecting concentrations of corticosterone (cort) metabolites from northern bobwhite fecal samples. Two physiological challenges and one biological challenge were applied to 18 northern bobwhites (nine males and nine females), and the fecal cort metabolite concentrations were compared to baseline levels. The interactions of sex and treatment, treatment and time and sex and time were all significant. Thus, the methods and tools used here were sensitive enough to detect expected changes to the hypothalamo–pituitary–adrenal axis of northern bobwhite.

28 October 2026 in International Journal for Parasitology: Parasites and Wildlife
Verified
Journal Article
Open access
TATimothy B. Arlowe
Timothy B. Arlowe
HSHannah N. Suber
Hannah N. Suber
JLJeremiah Leach
Jeremiah Leach
RKRonald J. Kendall
Ronald J. Kendall

27 March 2026 in International Journal for Parasitology: Drugs and Drug Resistance
Verified
Journal Article
Open access
HSHannah N. Suber
Hannah N. Suber
DPDhavalkumar Patel
Dhavalkumar Patel
TATimothy B. Arlowe
Timothy B. Arlowe
AKAshley Kaskocsak
Ashley Kaskocsak
HVHenry Valencia
Henry Valencia
RKRonald J. Kendall
Ronald J. Kendall
The northern bobwhite (Colinus virginianus) has experienced significant population declines across its native range. Parasitic nematodes are increasingly being recognized as contributing factors. QuailGuard®, an anthelmintic feed that uses fenbendazole (FBZ) as the active ingredient, has shown promise in field studies for reducing parasite loads in wild quail. However, little is known about the pharmacokinetics of FBZ in bobwhite, limiting accurate assessments of therapeutic exposure. This study investigated the pharmacokinetic profile of FBZ and its bioactive metabolite, oxfendazole (OFZ), in bobwhite fed QuailGuard®. Plasma concentrations were measured at multiple time points during (1, 2, 4, 8, and 24 h) and after (2, 4, 8, 24, and 32 h) feed administration using LC/MS-MS. Key pharmacokinetic parameters, including estimated area under the curve (AUC), apparent elimination rate, half-life, and mean residence time (MRT) were calculated using composite sampling. Peak average plasma concentrations of FBZ (2.3701 μg/mL) and OFZ (0.5526 μg/mL) occurred at 8 h post-ingestion. Estimated AUCs were 47.782 μg h/mL for FBZ and 12.783 μg h/mL for OFZ, with respective half-lives of 3.83 and 4.03 h. Combined drug exposure approached levels associated with the lethality of Oxyspirura petrowi in prior studies, indicating that intake over multiple weeks may achieve therapeutic efficacy. While sex did not affect analyte accumulation during treatment, females exhibited faster OFZ apparent elimination than males. FBZ and OFZ were rapidly absorbed and eliminated, which supports the safety of QuailGuard® for use in wild populations. These findings establish foundational pharmacokinetic data necessary for optimizing field treatment regimens and improving parasite control strategies in declining bobwhite populations.